Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | C. T. Hellwig et al., J. Biol. Chem., Aug 2008; 283: 21676 - 21685 | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | M. De Luca et al., J. Cell Sci., Jun 2014; 127: 2697 - 2708 | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | A. Raturi et al., J. Cell Biol., Aug 2016; 214, 433 - 444 | ||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | RNA-Interference | Metafectene EASY | publication | M. De Luca et al., J. Cell Sci., Jun 2014; 127: 2697 - 2708 | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | S. de la Fuente et al., Biochem. J., 2014, 458: 33-40, doi:10.1042/BJ20131025 | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | M. I. K. Hamad et al., Development, Apr 2014; 141: 1737 - 1748 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | M. Ahn et al., Human Gene Ther. Methods, 2012, 24: 1–10, DOI: 10.1089/hgtb.2012.198 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | J.-C. Park et al., 2017, US 2017/0100458 A1 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | A. Breit et al., J. Biol. Chem., Dec 2006; 281: 37447 - 37456 | Link | |
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | M. Arechederra et al., J. Biol. Chem., Feb 2015; 290: 4383 - 4397 | ||
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | N. P. Bendeck, Dissertation, 2016, Universidad Complutense de Madrid | Link | |
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | L. M. Williams, Dissertation, 2014, Royal College of Surgeons in Ireland | Link | |
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | T. Piyush et al., Cell Death Discovery, 2017, 3: 17044, doi:10.1038/cddiscovery.2017.44 | Link | |
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | N. Priego et al., Oncotarget, 2016, 7 (29): 45060-45078 | Link | |
Gsalpha-QL |
Human prostate cancer cell line that overexpresses the Gs-alpha protein (derivat of PC3) | Human | genital tract | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | K. A. Iczkowski et al., Anticancer Res, Jul 2006; 26: 2863 - 2872 | Link | ||
Gsalpha |
Human prostate cancer cell line that overexpresses the Gs-alpha protein (derivat of PC3) | Human | genital tract | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | K. A. Iczkowski et al., Mol Biotechnol, Oct 2004; 28(2): 97-103 | |||
Gsalpha |
Human prostate cancer cell line that overexpresses the Gs-alpha protein (derivat of PC3) | Human | genital tract | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | A. L. Omara-Opyene et al., Lab Invest., 2004 Jul; 84(7):894-907 | |||
GL15 |
Human glioblastoma cell line | Human | brain | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | R. Xie et al., Oncology Reports, 2013, 29: 177-184, 2013, DOI: 10.3892/or.2012.2102 | Link | ||
G3K |
Human pancreas carcinoma cell line (derivat of MIA PaCa-2) | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | L. Qin, PhD Thesis, 2014, Indiana University | |||
CCD 841 CoTr |
Human normal colon epithel cell line | ATCC CRL-1807 | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | L. M. Williams, Dissertation, 2014, Royal College of Surgeons in Ireland | Link | |
C3H/10T1/2 |
Mouse embryonic mesenchymal cell line | ATCC CCL-226 | Mouse | unknown | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | T. Wang et al., Phytotherapy Research., 2019, 33: 1074–1083, DOI: 10.1002/ptr.6301 | Link | |
A375-P |
Human melanona cell line | ATCC CRL-3224 | Human | skin | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | A. Raturi et al., J. Cell Biol., Aug 2016; 214, 433 - 444 | ||
A375 |
Human skin malignant melanoma cell line | ATCC CRL-1619 | Human | skin | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | E. Cesaro et al., Research Square, 2021, DOI: https://doi.org/10.21203/rs.3.rs-278700/v1 | Link | |
A375 |
Human skin malignant melanoma cell line | ATCC CRL-1619 | Human | skin | cell line | adherent | plasmid | RNA-Interference | K2 Transfection System | publication | M. Tufano et al., Front. Cell Dev. Biol., 2021, 9: 718947, doi: 10.3389/fcell.2021.718947 | Link | |
A-2058 |
Human skin melanoma cell line | ATCC CRL-11147 | Human | skin | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | E. Cesaro et al., Research Square, 2021, DOI: https://doi.org/10.21203/rs.3.rs-278700/v1 | Link |